Self-assembling sequentially administered tumor targeted Split IL-12p35 and p40 subunits to improve the therapeutic index of systemically delivered IL-12 therapy for cancer

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 92f5fef73e0b9e74-LAX IP: 118.31.43.22 UTC time: 2025-04-12T22:00:20+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4